Table 2 Highly enriched KEGG pathways for putative human targets
From: Exploration of miRNAs in Neolamarckia cadamba and their potential cross-kingdom functions
Term | ID | Input number | P-Value |
|---|---|---|---|
Vibrio cholerae infection | hsa05110 | 18 | 4.93E-03 |
Proteoglycans in cancer | hsa05205 | 72 | 1.53E-02 |
Melanoma | hsa05218 | 30 | 1.86E-02 |
Pathways in cancer | hsa05200 | 107 | 2.09E-02 |
Insulin signaling pathway | hsa04910 | 51 | 2.66E-02 |
Glioma | hsa05214 | 27 | 2.86E-02 |
ErbB signaling pathway | hsa04012 | 34 | 2.91E-02 |
Bile secretion | hsa04976 | 29 | 3.17E-02 |
Aldosterone-regulated sodium reabsorption | hsa04960 | 18 | 3.34E-02 |
Endocrine and other factor-regulated calcium reabsorption | hsa04961 | 21 | 3.40E-02 |
Long-term potentiation | hsa04720 | 27 | 3.70E-02 |
SNARE interactions in vesicular transport | hsa04130 | 16 | 3.86E-02 |
Focal adhesion | hsa04510 | 69 | 4.14E-02 |
Bladder cancer | hsa05219 | 17 | 4.61E-02 |
Synaptic vesicle cycle | hsa04721 | 25 | 4.90E-02 |
Signaling pathways regulating pluripotency of stem cells | hsa04550 | 49 | 5.12E-02 |
Thyroid hormone signaling pathway | hsa04919 | 42 | 5.30E-02 |
Retrograde endocannabinoid signaling | hsa04723 | 37 | 5.58E-02 |